A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

by | May 6, 2026 | Clinical Trials | 0 comments

​ Conditions: Malignant Neoplasm of Brain

Interventions: Drug: NBM-BMX Capsule; Drug: Temozolomide

Sponsors: Novelwise Pharmaceutical Corporation

Recruiting Conditions: Malignant Neoplasm of Brain
Interventions: Drug: NBM-BMX Capsule; Drug: Temozolomide
Sponsors: Novelwise Pharmaceutical Corporation
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *